Jinke Cheng

Dr. Jinke Cheng


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
WLWenwen Li
Wenwen Li
LLLu Lu
Lu Lu
JLJuanjuan Lu
Juanjuan Lu
XWXinran Wang
Xinran Wang
CYChao Yang
Chao Yang
LDLiufu Deng
Liufu Deng
Cell-intrinsic cGAS-STING–mediated DNA sensing promotes the formation of stem cell–like CD8 + T cells for effective cancer T cell therapy.

1 August 2019 in Molecular Cell
Verified
Journal Article
Closed access
TWTianshi Wang
Tianshi Wang
YCYing Cao
Ying Cao
QZQuan Zheng
Quan Zheng
JTJun Tu
Jun Tu
WZWei Zhou
Wei Zhou
JCJinke Cheng
Jinke Cheng

1 November 2016 in Molecular Cell
Verified
Journal Article
Closed access
YWYi-Ping Wang
Yi-Ping Wang
WZWei Zhou
Wei Zhou
JWJian Wang
Jian Wang
XHXian Huang
Xian Huang
YZYong Zuo
Yong Zuo
QLQun-Ying Lei
Qun-Ying Lei

8 October 2021 in Science Advances
Verified
Journal Article
Open access
YYYuanqin Yang
Yuanqin Yang
MWMeng Wu
Meng Wu
DCDongqing Cao
Dongqing Cao
CYChao Yang
Chao Yang
JJJingsi Jin
Jingsi Jin
LDLiufu Deng
Liufu Deng
ZBP1-MLKL necroptotic signaling bridges tumor cell damage to antitumor immune responses after radiation.

1 April 2010 in Molecular Cell
Verified
Journal Article
Closed access
XKXunlei Kang
Xunlei Kang
YQYitao Qi
Yitao Qi
YZYong Zuo
Yong Zuo
QWQi Wang
Qi Wang
YZYanqiong Zou
Yanqiong Zou
EYEdward T.H. Yeh
Edward T.H. Yeh

Verified
Journal Article
Open access
PDF file
XWXiangyun Wei
Xiangyun Wei
XLXiaohe Li
Xiaohe Li
SHShuming Hu
Shuming Hu
JCJinke Cheng
Jinke Cheng
RCRong Cai
Rong Cai
Lung adenocarcinoma (LUAD) is the most common lung cancer, which accounts for about 35–40% of all lung cancer patients. Despite therapeutic advancements in recent years, the overall survival time of LUAD patients still remains poor, especially KRAS mutant LUAD. Therefore, it is necessary to further explore novel targets and drugs to improve the prognos is for LUAD. Ferroptosis, an iron-dependent regulated cell death (RCD) caused by lipid peroxidation, has attracted much attention recently as an alternative target for apoptosis in LUAD therapy. Ferroptosis has been found to be closely related to LUAD at every stage, including initiation, proliferation, and progression. In this review, we will provide a comprehensive overview of ferroptosis mechanisms, its regulation in LUAD, and the application of targeting ferroptosis for LUAD therapy.